A XM não fornece serviços a residentes nos Estados Unidos da América.

Futures jump as growth stocks lead gains after Fed cuts rates



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Futures jump as growth stocks lead gains after Fed cuts rates</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

BofA expects Fed to go for 75-bp cut in Q4

US big banks rise after Fed's jumbo rate cut

Futures up: Dow 1.1%, S&P 500 1.6%, Nasdaq 2.07%

Updated at 7:17 a.m. ET/1117 GMT

By Johann M Cherian and Purvi Agarwal

Sept 19 (Reuters) -U.S. stock index futures jumped onThursday, with those linked to the tech-heavyNasdaq climbing 2% after theFederal Reserve started its easing cycle with a jumbo 50-basis-point cutto interest rates, aiding a soft landing for the world's biggest economy.

Rate-sensitive growth stocks that have led much of this year's rally such asMicrosoft MSFT.O, Meta META.O and AlphabetGOOGL.O advanced 2% inpremarket trading.

Semiconductor stocks also climbed. Nvidia NVDA.O rose 3.2%, while AdvancedMicro Devices AMD.O and Broadcom AVGO.O gained3.3% with the broader market.

Futures tracking the domestically focused Russell 2000 index RTYc1 shot up 3%.

A lower interest environment could mean prospects of lower operatingcosts and greater profits for credit-dependent companies.

At 7:17 a.m. ET, Dow E-minis 1YMcv1 were up 456 points, or 1.1%, S&P 500 E-minis EScv1 were up 91.25 points, or 1.61% and Nasdaq 100 E-minis NQcv1 were up 404.75 points, or 2.07%.

After delivering its super-sized verdict on Thursday, the Fed assured that it was not an emergency response and unveiled projections that analysts say reflect conditions for the economy to achieve a goldilocks scenario, where growth is steady and inflation and unemployment stay low.

"The Fed took out an insurance policy against further labor market weakening. Chair (Jerome) Powell emphasized that there are no signs of an imminent downturn in what he described as a 'strong economy'," said Ronald Temple, chief market strategist at Lazard.



Traders now see a 67% chance that the central bank will lower interest rates by 25 basis points at its November meeting, as per the CME Group's FedWatch tool.

BofA Global Research now anticipates a total of 75 bps rate cuts by the end of this year, compared with 50 bps forecast earlier.Citigroup revised its rate-cut expectations for December to a smaller 25 bps, from a forecast of a bigger move.

Goldman Sachs now expects consecutive 25 bps cuts from November 2024 through June 2025.

Market reaction in the aftermath of the decision was muted, with all the three indexes closing slightly lower in the previous session.

However, data going back to 1970 from Evercore ISI showed the S&P 500 has posted an average 14% gain in the six months following the first reduction of a rate-cutting cycle.

September has generally been a disappointing month for U.S. equities with the S&P 500 .SPX notching an average loss of 1.2% since 1928.

The benchmark index haslogged losses so far this month but is close to record highs, and the blue-chip Dow .DJI is just short of its respective milestone.

On the data front, weekly jobless claims and existing home sales for August are on investors' radar.

JPMorgan Chase & Co JPM.N added 1.1%, Bank of America BAC.N climbed 1.7% and Wells Fargo WFC.N advanced 1.8% after the big banks lowered their respective prime rates. Citigroup C.N also rose 1.9% after cutting its base lending rate.

Progyny PGNY.O was among a few stocks that traded lower. The fertility benefits management firm plunged 26% after a significant client notified the company it had elected to exercise a 90-day optionto terminate its services agreement.


US inflation and interest rates https://reut.rs/4esuPHd


Reporting by Johann M Cherian and Purvi Agarwal in Bengaluru; Editing by Nivedita Bhattacharjee and Maju Samuel

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.